Diagnosis & Disease Information

Clinical Charts

Hormone Replacement Therapies

April 4, 2022

Chart with different formulations and combination of drugs used to treat menopause.

Gynecologic Cancer

Tivdak Approved for Recurrent or Metastatic Cervical Cancer

Brian Park, PharmD

September 21, 2021

The approval was based on data from the phase 2 innovaTV 204 trial that evaluated Tivdak as monotherapy in 101 women with recurrent or metastatic cervical cancer.

Next post in Gynecologic Cancer

Diagnosis & Disease Information

Hormone Replacement Therapies

Tivdak Approved for Recurrent or Metastatic Cervical Cancer

Earlier Elimination of Cervical Cancer Projected in Low-Poverty U.S. Counties